Tsart Trio 6.25 Tablet
Marketer
Alkem Laboratories Ltd
Salt Composition
Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)
Overview Tsart Trio 6.25 Tablet
Tri-Med 6.25mg tablets combine multiple medications to manage hypertension when monotherapy proves insufficient. This formulation effectively lowers elevated blood pressure, consequently reducing the risk of future strokes and heart attacks. Administer Tri-Med 6.25mg with food; dosage is individualized based on patient response and condition. Maintain consistent daily timing. Continuous use, as directed by your physician, is crucial. Due to its diuretic component, avoid taking it within four hours of bedtime to minimize nighttime urination. Consistent use is key to maximizing therapeutic benefits, even during asymptomatic periods. Discontinuing treatment elevates the risk of cardiovascular events. Common side effects may include ankle edema, cephalalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor immediately. Increase fluid intake to mitigate potential dehydration symptoms such as muscle weakness, xerostomia, and excessive thirst. Prior to commencement, disclose any liver or kidney dysfunction to your doctor; pregnant or lactating individuals should seek medical guidance. Inform your physician of all concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, electrolytes, and blood glucose is essential to ensure optimal therapeutic efficacy.
Uses of Tsart Trio 6.25 Tablet
Elevated blood pressure
Major Benefits of Tsart Trio 6.25 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Tsart Trio 6.25 Tablets should be administered with a meal.
Common Side effects of Tsart Trio 6.25 Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Tsart Trio 6.25 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Tsart Trio 6.25 Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.
How Tsart Trio 6.25 Tablet works:
Tsart Trio 6.25mg tablets contain Telmisartan, Cilnidipine, and Chlorthalidone, three medications working synergistically to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and Cilnidipine, a dihydropyridine calcium channel blocker, both promote vasodilation, reducing blood pressure. Chlorthalidone, a thiazide diuretic, facilitates diuresis, eliminating excess fluid and electrolytes, contributing to both short-term and long-term blood pressure reduction via enhanced vascular relaxation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tsart Trio 6.25 Tablet and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Tsart Trio 6.25 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on Tsart Trio 6.25 Tablet use while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Tsart Trio 6.25 Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Tsart Trio 6.25mg tablets, as dose modification may be necessary. Physician consultation is advised; this medication is generally unsuitable for such patients.
LiverCAUTION
Patients with liver impairment should exercise caution when using Tsart Trio 6.25 mg tablets; dosage modification may be necessary. Physician consultation is advised. Tsart Trio 6.25 mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Tsart Trio 6.25 Tablet :
Should you forget a Tsart Trio 6.25 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tsart Trio 6.25 Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Category | HEART |






